| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Windtree Therapeutics Inc /de/ (WINT) has 0 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. WINT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | Huang James | Director, 10% Owner | Buy | 400 | $3.84 | $1,535.00 | +1.7% | |
| Feb 11, 2020 | Fraser Craig | President And CEO | Buy | 500 | $4.10 | $2,050.00 | +0.4% | |
| Feb 7, 2020 | Huang James | Director, 10% Owner | Buy | 500 | $4.05 | $2,025.00 | +2.2% | |
| Feb 4, 2020 | Fraser Craig | President And CEO | Buy | 600 | $4.23 | $2,540.00 | +0.5% | |
| Jan 17, 2020 | Huang James | Director, 10% Owner | Buy | 2,058 | $4.18 | $8,609.40 | +5.0% | |
| Dec 31, 2019 | Huang James | Director, 10% Owner | Buy | 15,442 | $4.05 | $62,524.66 | +308.8% | |
| Dec 30, 2019 | Huang James | Director, 10% Owner | Buy | 5,000 | $3.74 | $18,723.95 | +122.2% | |
| Dec 6, 2019 | Lee's Pharmaceutical Holdings Ltd | 10% Owner | Buy | 1,655,629 | $3.02 | $4,999,999.58 | +12.9% | |
| Dec 6, 2019 | Lph II Investments Ltd | 10% Owner | Buy | 1,655,629 | $3.02 | $4,999,999.58 | +70.4% | |
| Dec 6, 2019 | Huang James | Director, 10% Owner | Buy | 1,655,629 | $3.02 | $4,999,999.58 | +36.6% |